Clinical Trial: An exploratory study to evaluate the tolerability, safety, and efficacy of ¹⁷⁷Lu-HGC254 in patients with advanced solid tumors (China)

Posted On: 2026-09-21

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An exploratory study to evaluate the tolerability, safety, and efficacy of ¹⁷⁷Lu-HGC254 in patients with advanced solid tumors'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132914

Registration Time: 2026/09/20

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343363

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: An exploratory study to evaluate the tolerability, safety, and efficacy of ¹⁷⁷Lu-HGC254 in patients with advanced solid tumors (China)